Question 1

Does Baker Bros. Advisors own ALGS stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Baker Bros. Advisors holds 83,055 shares of ALGS (Aligos Therapeutics), worth $479,227.

Question 2

How many shares of ALGS does Baker Bros. Advisors own?

Accepted Answer

As of its Q2 2026 13F, Baker Bros. Advisors holds 83,055 shares of ALGS (Aligos Therapeutics).

Question 3

What is Baker Bros. Advisors' ALGS position worth?

Accepted Answer

As of its Q2 2026 13F, Baker Bros. Advisors' ALGS position is worth $479,227.

Question 4

When did Baker Bros. Advisors first buy ALGS?

Accepted Answer

Baker Bros. Advisors first reported ALGS in its Q3 2024 13F and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Unchanged	83,055	0.0%	$479,227	0.0%	$5.77	0
2026-Q1	Unchanged	83,055	0.0%	$617,099	0.0%	$6.85	0
2025-Q4	Unchanged	83,055	0.0%	$774,073	0.0%	$9.12	0
2025-Q3	Unchanged	83,055	0.0%	$813,939	0.0%	$9.62	0
2025-Q2	Unchanged	83,055	0.0%	$598,827	0.0%	$7.21	0
2025-Q1	Unchanged	83,055	0.0%	$685,204	0.0%	$9.12	0
2024-Q4	Unchanged	83,055	0.0%	$3.3M	0.0%	$40.47	0
2024-Q3	New	83,055	—	$719,256	0.0%	$8.04	34